Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study

<p>Abstract</p> <p>Background</p> <p>Self-administration of recombinant human follicle-stimulating hormone (r-hFSH) can be performed using injection pen devices by women undergoing assisted reproductive technology procedures. The objective of this study was to explore t...

Full description

Bibliographic Details
Main Authors: Welcker J, Nawroth Frank, Bilger Wilma
Format: Article
Language:English
Published: BMC 2010-09-01
Series:Reproductive Biology and Endocrinology
Online Access:http://www.rbej.com/content/8/1/111
id doaj-77447d577d2d444eb06ab5b1bf41afbb
record_format Article
spelling doaj-77447d577d2d444eb06ab5b1bf41afbb2020-11-24T22:14:39ZengBMCReproductive Biology and Endocrinology1477-78272010-09-018111110.1186/1477-7827-8-111Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational studyWelcker JNawroth FrankBilger Wilma<p>Abstract</p> <p>Background</p> <p>Self-administration of recombinant human follicle-stimulating hormone (r-hFSH) can be performed using injection pen devices by women undergoing assisted reproductive technology procedures. The objective of this study was to explore the use of the prefilled follitropin alfa pen in routine assisted reproductive technology procedures in Germany.</p> <p>Methods</p> <p>This prospective, observational study was conducted across 43 German IVF centres over a period of 1.75 years. Patients who had used the prefilled follitropin alfa pen in the current or a previous cycle of controlled ovarian stimulation completed a questionnaire to assess their opinions of the device.</p> <p>Results</p> <p>A total of 5328 patients were included in the study. Of these, 2888 reported that they had previous experience of daily FSH injections. Significantly more patients reported that less training was required to use the prefilled follitropin alfa pen than a syringe and lyophilized powder (1997/3081 [64.8%]; p < 0.001 'less' versus 'more' training). Significantly more patients rated the prefilled follitropin alfa pen as easier in terms of use (2321/3206, 72.4%; p < 0.001 'much more easy' versus 'less easy') and daily injection (2384/3262, 73.1%; p < 0.001 'much more easy' versus 'less easy') than existing injection methods. Approximately one third of respondents rated the prefilled follitropin alfa pen as easier to use than the follitropin beta pen with reloadable cartridges. The majority (3378/4024, 83.9%) of patients had a general preference for the prefilled follitropin alfa pen over other injection methods.</p> <p>Conclusions</p> <p>In this questionnaire-based survey, routine use of the prefilled follitropin alfa pen was well accepted and associated with favourable patient perceptions. Users of the pen found it easier to initially learn how to use, and subsequently use, than other injection methods. In general, the prefilled follitropin alfa pen was the preferred method for self-administration of gonadotrophins. Together with previous findings, the results here indicate a high level of patient satisfaction among users of the prefilled follitropin alfa pen for daily self-administration of r-hFSH.</p> http://www.rbej.com/content/8/1/111
collection DOAJ
language English
format Article
sources DOAJ
author Welcker J
Nawroth Frank
Bilger Wilma
spellingShingle Welcker J
Nawroth Frank
Bilger Wilma
Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
Reproductive Biology and Endocrinology
author_facet Welcker J
Nawroth Frank
Bilger Wilma
author_sort Welcker J
title Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
title_short Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
title_full Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
title_fullStr Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
title_full_unstemmed Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
title_sort patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
publisher BMC
series Reproductive Biology and Endocrinology
issn 1477-7827
publishDate 2010-09-01
description <p>Abstract</p> <p>Background</p> <p>Self-administration of recombinant human follicle-stimulating hormone (r-hFSH) can be performed using injection pen devices by women undergoing assisted reproductive technology procedures. The objective of this study was to explore the use of the prefilled follitropin alfa pen in routine assisted reproductive technology procedures in Germany.</p> <p>Methods</p> <p>This prospective, observational study was conducted across 43 German IVF centres over a period of 1.75 years. Patients who had used the prefilled follitropin alfa pen in the current or a previous cycle of controlled ovarian stimulation completed a questionnaire to assess their opinions of the device.</p> <p>Results</p> <p>A total of 5328 patients were included in the study. Of these, 2888 reported that they had previous experience of daily FSH injections. Significantly more patients reported that less training was required to use the prefilled follitropin alfa pen than a syringe and lyophilized powder (1997/3081 [64.8%]; p < 0.001 'less' versus 'more' training). Significantly more patients rated the prefilled follitropin alfa pen as easier in terms of use (2321/3206, 72.4%; p < 0.001 'much more easy' versus 'less easy') and daily injection (2384/3262, 73.1%; p < 0.001 'much more easy' versus 'less easy') than existing injection methods. Approximately one third of respondents rated the prefilled follitropin alfa pen as easier to use than the follitropin beta pen with reloadable cartridges. The majority (3378/4024, 83.9%) of patients had a general preference for the prefilled follitropin alfa pen over other injection methods.</p> <p>Conclusions</p> <p>In this questionnaire-based survey, routine use of the prefilled follitropin alfa pen was well accepted and associated with favourable patient perceptions. Users of the pen found it easier to initially learn how to use, and subsequently use, than other injection methods. In general, the prefilled follitropin alfa pen was the preferred method for self-administration of gonadotrophins. Together with previous findings, the results here indicate a high level of patient satisfaction among users of the prefilled follitropin alfa pen for daily self-administration of r-hFSH.</p>
url http://www.rbej.com/content/8/1/111
work_keys_str_mv AT welckerj patientevaluationoftheuseoffollitropinalfainaprefilledreadytouseinjectionpeninassistedreproductivetechnologyanobservationalstudy
AT nawrothfrank patientevaluationoftheuseoffollitropinalfainaprefilledreadytouseinjectionpeninassistedreproductivetechnologyanobservationalstudy
AT bilgerwilma patientevaluationoftheuseoffollitropinalfainaprefilledreadytouseinjectionpeninassistedreproductivetechnologyanobservationalstudy
_version_ 1725797867810979840